(3-blocking, antiarrhythmic, and local anesthetic effects of the racemic mixture and optical isomers of bucumolol, 5-methyl-8-(2-hydroxy-3-t-butylamino propoxy) coumarin hydrochloride, were studied in dogs, guinea-pigs and frogs. In blocking the positive chronotropic response to isoproterenol, the levo-isomer of bucumolol was about 40 times more potent in dogs, and 270 times in guinea-pigs than its dextro-isomer and twice as effective in both species as the racemic mixture. In frog sciatic nerves bucumolol was 1/10-1115 as potent in local anesthetic action as propranolol on a weight basis. Dextro and levo-isomers and racemic bucumolol neither elevated electrical threshold for propagated impulses nor prolonged the effective refractory period of the dog right atrium. The levo-isomer and racemic bucumolol were capable of suppressing aconitine-induced atrial arrhythmia, while the dextro-isomer was less effective Both isomers and racemic bucumolol were capable of reversing ventricular arrhythmia caused by ouabain, but the effective dose of the levo-isomer was significantly less than that of the dextro-isomer.
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The results suggest that both specific jS-blocking activity and non-specific membrane action of bucumolol suppressed experimental arrhythmias in dogs produced by aconitine and ouabain. Hashimoto and associates compared the potencies of various / -blocking agent in antagonizing positive chronotropic (1, 2) and inotropic responses (3, 4) to isoproterenol and to noradrenaline in excised and blood-perfused sino-atrial node and papillary muscle preparations of dogs.
We later compared the antiarrhythmic effects of these compounds on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs, and concluded that some ;3-blocking agents were effective in suppressing these experimental arrhythmias but their effectiveness did not parallel the l3-blocking activity (5-7).
Concerning antiarrhythmic effect, !3-blocking agents such as sotalol (8) (12) found that dose-response curves for percentage reduction in ouabain-induced ventricular fibrillation by those drugs were straight and parallel, indicating that 1NPEA was also effective but the effectiveness of INPEA was only 0.02 that of pindolol. This discrepancy may be due to the different animal species used or to the procedures for testing antiarrhythmic effects. If optical isomers, though difficult to obtain, were available, this discrepancy might be overcome.
5-Methyl-8-(2-hydroxy-3-t-butylamino-propoxy)coumarin hydrochloride (bucumolol) used in this study is a ,3-blocking agent which is approximately 3 times more potent than propranolol in blocking isoproterenol-induced positive chronotropic (7, 13) and inotropic responses (4) in dogs and guinea-pigs. The structural formula of bucumolol is shown in The heart rate was measured continuously by means of a cardiotachograph (Nihon Kohden RT-2) triggered by R wave of ECG lead II. The ;3-blocking activity was assessed against the positive chronotropic response to 0.3 /ig/kg i.v. of isoproterenol, which was administered about 3 min after a given dose of a 13-blocking agent from 3 to 1000 ,,tg/kg. Then, every 20 min, isoproterenol in the same dose was given until the positive chronotropic response to isoproterenol recovered to the control level.
The guinea-pig right atria were isolated and suspended in Tyrode Solution. Rate of spontaneous contraction was augmented by 10-1 g/ml of isoproterenol and the degree of blockade was calculated according to the method of Saameli (14) . Test compounds were administered by intravenous infusion at a constant rate to block arrhythmia within a period of 10 to 30 min. When an antiarrhythmic effect did not appear after intravenous infusion for 40 min, the infusion of the drug was interrupted and the result was interpreted as negative. 
RESULTS
The data represent findings in 5-7 dogs. The mean heart rate was 16012 (N==20).
The mean increase in heart rate produced by 0.3 /cg/kg i.v. of isoproterenol was 70--6 beats/min. The j3-blocking effect of bucumolol and its optical isomers were assessed against this positive chronotropic response. The increase in contraction rate of the guinea-pig right atrium preparation with 10'8 g/ ml of isoproterenol was compared before and after increasing concentrations of bucumolol or its optical isomers (Fig. 2, lower panel) . Four experiments were performed with each compound. The mean concentration required to produce 50% attenuation of the response to isoproterenol was 2.7x 10-9 g/ml of the 1-isomer, while it was 5.5 x 10-' g/ml of the d
isomer. The ratio of !3-blocking activity of racemic mixture, 1 and d-isomers of bucumolol was 1:2.37:0.01.
Effects of bucumolol and its optical isomers, propranolol and quinidine on the effective refractory period of the dog right atrium : Racemic mixture of bucumolol at two dose levels, 0.3 and 5 mg/kg i.v., neither altered the threshold nor prolonged the refractory periods significantly ( Table 1 ). Dextro and levo-isomers of bucumolol also were without significant effects on the threshold or effective refractory period. There was no significant difference in these effects between both isomers at a dose of 0.3 or 1 mg/kg i.v. On the other hand,
propranolol at a dose of 0.3 or 5 mg/kg i.v. significantly increased both the threshold and refractory period ( Table 1) . Effects of quinidine increased significantly the refractory period but did not change the threshold (Table 1) . (Table 3 ) and right vagal stimulation induced prominent bradycardia, as shown in Fig. 3 . The infusion of the drug was continued until it reached a total of 15 mg/kg. The duration of antiarrhythmic action lasted over 90 min, except for one case of dl-bucumolol. As summarized in Table 3 , both d and ]-isomers were capable of sup pressing the heterotopic ventricular arrhythmia induced by ouabain. However, the anti arrhythmic dose of 1-isomer of bucumolol was significantly different from that of either d-isomer or racemic mixture (p<0.05). The antiarrhythmic dose had little effect on the systemic blood pressure and heart rate when the values before ouabain and after reversal to sinus rhythm were compared (p<0.01).
DISCUSSION
Previous studies showed that /3-blocking activity of dl-bucumolol was three times that of propranolol (2, 4, 7, 13) but its local anesthetic activity was about 1/10 that of the latter (7) . The present study confirmed these previous results.
In frog sciatic nerve d-, 1 and dl-bucumolol all had local anesthetic activity, and in this respect were equipotent. In the dog right atrium, both isomers and racemic bucumolol failed to elevate the electrical threshold for propagated impulses to be elicited or to prolong the effective refractory period. In contrast to these findings, the /3-blocking effect of the 1-isomer was about 40 times that of the d-isomer and twice that of the racemic compound. Purkinje fibers a specific increase in sodium conductance and a simultaneous inhibition of inactivation of the sodium carrier system. This could make the membrane unstable and an extrasystole would occur before repolarization is complete. As catecholamines accelerate the reactivation process, they may play a role in aconitine-induced arrhythmia by making the cardiac membrane unstable in the repolarization phase.
As to ouabain-induced ventricular arrhythmia, opinions on the effect of /3-adrenoceptors are controversial. Howe and Shanks (19) reported that racemic propranolol and its optical isomers were equally effective in abolishing ouabain-induced arrhythmia, while the ]-isomer was a little more effective. Lucchesi et al. (20) , and Whitsitt and Lucchesi (21) found that both i and d-isomer of either propranolol or pronethalol were capable of suppressing ectopic ventricular automaticity induced by ouabain, and such suggests that there is no special relation between fl-blocking action and prevention of ouabain-induced arrhythmia. Somani and others demonstrated that local anesthetic action was essential for antiarrhythmic activity of j3-blocking agents (22, 23 Tse and Han also found that ouabain enhanced the action of catecholamine on the auto maticity of Purkinje fibers causing ventricular arrhythmia (32) .
The mechanism by which ,3-blocking drugs act as antiarrhythmic is apparently complex.
Evans et al. (33) demonstrated that the ;3-blocking agent, nadolol, lacking in membrane depressant action was relatively ineffective in suppressing existing arrhythmia induced by digoxin. However, in the present experiments the 1-isomer and racemic bucumolol were capable of suppressing aconitine-induced atrial arrhythmia, while the d-isomer was less effective. Furthermore, both isomers and racemic bucumolol reversed ventricular arrhythmia induced by ouabain but the effective dose of the 1-isomer was significantly less than that of the d-isomer. The differences in incidence of effective cases and effective doses between optical isomers of bucumolol in suppressing either aconitine-induced atrial or ouabain induced ventricular arrhythmia in dogs might to some extent be related to f3-blockade. It is probable that in dogs, the activity of sympathetic mechanisms played some role in the initiation as well as the maintenance of experimental arrhythmias produced by aconitine and ouabain and that both specific ,3-blocking activity and non-specific membrane action of bucumolol suppressed these arrhythmias.
